Fondaparinux.

The Journal of the American Academy of Orthopaedic Surgeons

Volumn 12, Issue 6, 2004, Pages 371-375

  Turpie, Alexander G G ^a   Eriksson, Bengt I ^a   Bauer, Kenneth A ^a   Lassen, Michael R ^a  

^a HAMILTON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; POLYSACCHARIDE;

BIOAVAILABILITY; COST BENEFIT ANALYSIS; DOSE RESPONSE; DRUG ADMINISTRATION; ECONOMICS; FEMALE; FOLLOW UP; HIP PROSTHESIS; HUMAN; KNEE PROSTHESIS; MALE; METHODOLOGY; ORTHOPEDIC SURGERY; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME; VEIN THROMBOSIS;

BIOLOGICAL AVAILABILITY; CLINICAL TRIALS, PHASE III; COST-BENEFIT ANALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIP PROSTHESIS; HUMANS; KNEE PROSTHESIS; MALE; ORTHOPEDIC PROCEDURES; POLYSACCHARIDES; POSTOPERATIVE COMPLICATIONS; RISK ASSESSMENT; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 16644392844     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/00124635-200411000-00001     Document Type: Review

References (19)